Alberto Rossi

This inventor holds 28 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Ciba-Geigy Corporation, Ciba-Geigy Ag. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alberto Rossi. Retrieved from https://idiyas.com/inventor/alberto-rossi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 111(Granted Patents)

Company Filing History:

27 out of 6,858

Ciba-Geigy Corporation

Years Active: 1976-1985

Loading Chart...

Areas of Expertise:

Pharmaceutical Preparations

Anthranilamides

Benzopyrane Derivatives

Anti-Inflammatory Agents

Aryl-Chalcogeno Derivatives

Dicarboxylic Acids

Hydronaphthalene Compounds

Oxoalkylpyridines

Phenylazacycloalkanes

Sulphamoylbenzoic Acids

Furanose-O-Pyridylcarboxylic Acids

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4505913 - Substituted anthranilamides and pharmaceutical preparations containing (1985-03-19),

2. 4327091 - N,N-Di and N,N,N-tri(hydroxy-lower alkyl) ammonium salts of substituted (1982-04-27),

3. 4297358 - Novel 4,7-phenanthroline derivatives and pharmaceutical compositions (1981-10-27),

4. 4288450 - Process for the preparation of novel benzopyrane derivatives (1981-09-08),

5. 4272547 - Benzoyl indane carboxamides as antiphlogistics (1981-06-09),

6. 4263455 - Novel 2-sulphonyl- (or -sulphinyl)-2'-aminoacetophenones (1981-04-21),

7. 4216155 - Process for the preparation of novel benzopyrane derivatives (1980-08-05),

8. 4213980 - Azathianaphthalenes (1980-07-22),

9. 4192873 - Anti-inflammatory 2-sulphonyl- (or -sulphinyl)-2'-aminoacetophenones (1980-03-11),

10. 4192868 - Novel aryl-hexafuranosides and processes for their preparation (1980-03-11),

11. 4188396 - New phenylazacycloalkanes (1980-02-12),

12. 4177344 - Anhydro-sugars (1979-12-04),

13. 4115416 - Process for the manufacture of new carboxylic acids (1978-09-19),

14. 4112099 - Cyclo aliphatic-phenylene-carbonyl-pyridines (1978-09-05),

15. 4112075 - Furanose-O-pyridylcarboxylic acid esters (1978-09-05),

Title: **Alberto Rossi: Innovator in Pharmaceutical Patents from Oberwil, CH**

Introduction

Alberto Rossi, a prolific inventor based in Oberwil, Switzerland, has made significant contributions to the field of pharmaceuticals with 28 patents to his name. His innovative work primarily focuses on developing new compounds that exhibit therapeutic properties, particularly in alleviating pain and inflammation.

Latest Patents

Rossi's recent patents highlight his expertise in creating substituted anthranilamides and pharmaceutical preparations containing these compounds. One notable patent details a formula wherein various chemical groups, including hydrogen, aliphatic hydrocarbons, and aromatic radicals, come together to offer analgesic, anti-inflammatory, and anti-allergic benefits. These compounds are synthesized through specific reactions involving acids and amines, showcasing Rossi's commitment to advancing the pharmaceutical landscape with effective medicinal solutions. Additionally, his work on N,N-di and N,N,N-tri(hydroxy-lower alkyl) ammonium salts of substituted 3,4-dihydro-2H-1,2-benzothiazine compounds emphasizes their anti-inflammatory uses, further extending his influence in medicinal chemistry.

Career Highlights

Throughout his career, Rossi has worked with esteemed organizations such as Ciba-Geigy Corporation and Ciba-Geigy AG, where he honed his skills and contributed to important research and development projects. His innovative approaches have led to significant advancements in pharmaceutical formulations, particularly those that address pressing medical needs.

Collaborations

Rossi has collaborated with notable colleagues in the field, including Georges Haas and Pier G. Ferrini. Their joint efforts have fostered a collaborative environment that not only enhances individual contributions but also pushes the boundaries of pharmaceutical research forward.

Conclusion

Alberto Rossi represents a dedicated inventor whose work in pharmaceuticals reflects a deep commitment to improving medical treatments. With a robust portfolio of patents and a history of collaboration with industry leaders, Rossi's contributions continue to shape the future of therapeutic innovations. His latest research promises to provide valuable advancements in the treatment of various health conditions, confirming his status as a prominent figure in the world of pharmaceutical inventions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]